Literature DB >> 10024431

Screening for hereditary fructose intolerance mutations by reverse dot-blot.

J Lau1, D R Tolan.   

Abstract

An assay is described which is useful for genetic screening of the two most prevalent mutations that cause hereditary fructose intolerance (HFI). Both mutations lie within exon 5 of the aldolase B gene. Amplification of exon 5 from genomic DNA isolated from peripheral lymphocytes using biotinylated aldolase B-specific primers yields a biotin-tagged probe. This probe is hybridized to complementary poly(dT)-tailed allele specific oligonucleotides (ASOs) that are bound to a nylon membrane. The length of the ASOs, the amount bound to the membrane and the time of hybridization are optimized for discrimination of all four alleles under the same hybridization conditions. Detection of biotinylated amplified DNA is performed by creating an avidin-alkaline phosphatase complex and visualization by chemiluminescence. This assay can rapidly detect the two mutations, A149P and A174D, which cause >70% of HFI worldwide, and offers a rapid and sensitive assay that is much less invasive for the diagnosis of this often difficult to diagnose disorder. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024431     DOI: 10.1006/mcpr.1998.0208

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  3 in total

1.  Simple method for detection of mutations causing hereditary fructose intolerance.

Authors:  C Kullberg-Lindh; C Hannoun; M Lindh
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

2.  Robot printing of reverse dot blot arrays for human mutation detection.

Authors:  S Lappin; J Cahlik; B Gold
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

Review 3.  "Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.

Authors:  Mark A Febbraio; Michael Karin
Journal:  Cell Metab       Date:  2021-10-06       Impact factor: 27.287

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.